CliffBio

Phathom Pharmaceuticals

Patent cliffs & loss of exclusivity

Novel treatments for gastrointestinal diseases and disorders

Company

Legal NamePhathom Pharmaceuticals, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.phathompharma.com/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/phathom-pharmaceuticals
Full Address100 Campus Drive, Suite 102 Florham Park, NJ 07932, US
LinkedIn URLhttps://www.linkedin.com/company/phathompharma/
Pitchbook URLhttps://pitchbook.com/profiles/company/267419-17
Seedtable URLhttps://seedtable.com/companies/phathom-pharmaceuticals

4 upcoming patent cliffs

DrugIngredientTypeCliff
  1. VOQUEZNA TRIPLE PAKAMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATESmall mol.May 2032
  2. VOQUEZNA DUAL PAKAMOXICILLIN; VONOPRAZAN FUMARATESmall mol.May 2032
  3. VOQUEZNAVONOPRAZAN FUMARATESmall mol.May 2032
  4. VOQUEZNAVONOPRAZAN FUMARATESmall mol.May 2032

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Phathom Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio